tiprankstipranks
Lixte Biotechnology Holdings (LIXT)
NASDAQ:LIXT
US Market
LIXT
Lixte Biotechnology Holdings
RESEARCH TOOLSreports

Lixte Biotechnology Holdings (LIXT) Income Statement

102 Followers

Lixte Biotechnology Holdings Income Statement

Last quarter (Q4 2025), Lixte Biotechnology Holdings's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Lixte Biotechnology Holdings's net income was $-2.54M. See Lixte Biotechnology Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 5.11M$ 3.57M$ 5.09M$ 6.31M$ 6.72M
Depreciation and Amortization
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
EBITDA
$ -6.00M$ -3.57M$ -5.07M$ -6.30M$ -6.72M
Operating Income
$ -5.11M$ -3.57M$ -5.09M$ -6.31M$ -6.72M
Other Income/Expenses
$ -901.90K$ -13.18K$ 3.21K$ -1.05K$ -7.95K
Pretax Income
$ -6.01M$ -3.59M$ -5.09M$ -6.31M$ -6.73M
Net Income
$ -6.01M$ -3.59M$ -5.09M$ -6.31M$ -6.73M
Per Share Metrics
Basic EPS
$ -1.26$ -1.59$ -2.66$ -4.00$ -5.00
Diluted EPS
$ -1.26$ -1.59$ -2.66$ -4.00$ -5.00
Weighted Average Shares Outstanding
 48.41M 2.25M 1.91M 1.58M 1.35M
Weighted Average Shares Outstanding (Diluted)
 48.41M 2.25M 1.92M 1.58M 1.35M
Currency in USD

Lixte Biotechnology Holdings Earnings and Revenue History